UVD Robots Selected by Global Facility Management Company ISS to Provide Autonomous Disinfection Robots
16.6.2021 16:02:00 EEST | Business Wire | Press release
Today, Blue Ocean Robotics the manufacturer of UVD Robots for autonomous UV-C disinfection announced that it was selected by ISS World Services, a world leading global workplace experience and facility management company, to provide autonomous robots for disinfection as part of ISS’ global offering.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210616005504/en/
UVD Robots are helping to ensure outstanding cleaning and disinfection excellence. Unlike many stationary disinfection systems, the UVD Robot is a mobile, fully autonomous robot integrating UV-C light to disinfect against all known bacteria and viruses including Covid-19 not only on surfaces, but the air as well, providing a fully comprehensive infection control and prevention solution. UVD Robots enable facilities to reduce disease transmission by eliminating 99.99 percent of bacteria and viruses in any room. The robots have been rolled out to more than 70 countries worldwide. (Photo: Business Wire)
The agreement allows ISS to offer hospital-grade disinfection to its more than 60,000 customers in 30+ countries in healthcare, pharmaceutical, life science, banking and financial services, industry & manufacturing sectors. UVD Robots enable facilities to reduce disease transmission by eliminating 99.99 percent of bacteria and viruses in any room.
“As we return to work, companies need to re-establish physical connections, bringing employees safely back to work environments meeting higher hygiene standards. And they need to restore the emotional connection, building employees’ confidence in the safety of their workplaces. Being able to offer disinfection, which also includes UVD Robots is a powerful, effective way for our company to address and meet customers’ needs and expectations,” says Anders Høj, Director, Methods & Technologies, Cleaning at ISS World Services.
Claus Risager, Blue Ocean Robotics’ CEO, looks forward to partnering with ISS. “Our robots continue to play instrumental roles in helping businesses meet requirements prompted by the pandemic and beyond, resulting in significant reductions in workplace infections while reducing the level of employees on sick leave. The UVD Robot has unique capabilities to sense, document and show users how well disinfected an area is, enabling users to easily and quickly adjust the process and optimize if needed. A feature not found in any other UV-C disinfection robot.”
About ISS
ISS, a leading workplace experience and facilities management company, provides placemaking solutions that contribute to better business performance and make life easier, more productive, and enjoyable – delivered to high standards by people who care. Learn more at issworld.com.
About UVD Robots
UVD Robots is part of one of the world's leading groups in development of service robots, Blue Ocean Robotics, that includes brands GoBe Robots and PTR Robots. Blue Ocean Robotics is headquartered in Denmark and recently made Fast Company’s Top 10 of ‘Most Innovative Robotics Companies 2021.’
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210616005504/en/
Contact information
Camilla Almind Knudsen,
PR Coordinator, Blue Ocean Robotics
+45 61 10 02 74
cak@blue-ocean-robotics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong20.7.2026 15:00:00 EEST | Press release
HistoSonics today announced the opening of its expanded Histotripsy Training Center in Hong Kong, reinforcing the city's position as a leading hub for physician education, clinical collaboration, and innovation in Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260720812810/en/ Pictured at the expanded Histotripsy Training Center in Hong Kong. Front row (left to right): Dr. Angus Yuen, Chief Medical Officer, Gleneagles Hospital Hong Kong; Prof. Albert Chan, Director of Liver Cancer Surgery Centre, Gleneagles Hospital Hong Kong; Dr. Kenneth Tsang, Regional Chief Executive Officer, IHH Healthcare North Asia, and Chief Executive Officer, Gleneagles Hospital Hong Kong; Dr. Vince Lau, Director of Interventional Radiology Centre, Gleneagles Hospital Hong Kong; Dr. Joe Herman, Vice President, Medical Affairs, HistoSonics. Back row (left to right): Jay Lee, APAC Regional Manager, HistoSonics; Eric Kwong, Hong Kong Sales Manager
Shaping a Generation Through Dialogue: Inside the Doha Debates Ambassador Program20.7.2026 14:29:00 EEST | Press release
In a world shaped by change and competing narratives, the ability to listen, question and engage in constructive dialogue has never been more critical. Through the Doha Debates Ambassador Program, a production of Qatar Foundation, young people from around the world are not only learning these skills, but actively applying them in their communities, careers and areas of study. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260720452437/en/ Shaping a Generation Through Dialogue: Inside the Doha Debates Ambassador Program. Applications are open for young people from around the world to learn to engage and lead through truth-seeking conversations about complex global issues. (Photo: AETOSWire) This online educational program teaches young people from across the globe to debate differently. Rather than engaging in a Western-style battle of ideas, participants take an approach to dialogue that is grounded in the Majlis—a welcoming
Kinaxis Appoints Herb Yeh as Chief Financial Officer and Chief Strategy Officer20.7.2026 14:01:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain planning and orchestration, today announced the appointment of Herb Yeh as Chief Financial Officer and Chief Strategy Officer, effective July 27, 2026. In this role, Yeh will oversee the global finance organization and corporate strategy operations at Kinaxis, leading all Finance, Accounting, Investor Relations, Corporate Strategy, and Corporate Development. He will work closely with the executive leadership team and Board of Directors to support disciplined execution, long-term growth, and shareholder value creation. "Herb has spent his career working with boards and management teams at their most critical inflection points in enterprise software, and we are thrilled to have him join Kinaxis," said Razat Gaurav, Chief Executive Officer of Kinaxis. "He has followed Kinaxis and the broader supply chain technology sector closely for more than a decade, and that depth of perspective, paired with his expertise advising companies on c
IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.20.7.2026 13:45:00 EEST | Press release
IFF (NYSE: IFF) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global provider of science-backed branded and functional ingredients, to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities, including its range of natural colors and antioxidants and certain localized flavor activities in Peru. The portfolio serves a broad range of food, beverage and nutritional end markets through a comprehensive selection of customized solutions. “These businesses are highly respected, and we are confident they will continue to thrive under the ownership of SuanNutra and Carbyne,” said Erik Fyrwald, CEO IFF. “This transaction is another step in optimizing our portfolio and reinforces our focus on our core innovation-led businesses — Taste, Scent and Health & Biosciences — where we see the greatest opportunities to drive
NIQ Appoints Irina Stoian as Chief AI Commercial Officer20.7.2026 13:45:00 EEST | Press release
NIQ today announced that Irina Stoian has joined the company as Chief AI Commercial Officer, a newly created role designed to accelerate NIQ’s enterprise AI commercial strategy and help clients turn the company’s AI capabilities into business impact and growth. Stoian will help align Product, Technology, Commercial, Partnerships, and Marketing around a unified AI growth strategy. Her remit includes shaping commercial AI offerings, strategic partnerships, pricing and business models, and deeper integration of NIQ capabilities into client workflows. The appointment builds on NIQ’s broader AI strategy, which positions the company as a trusted intelligence infrastructure powering AI-driven commerce. Across its AI portfolio, including ConnectAI, NIQ Optiq™, and NIQ Cadence™, NIQ is expanding how clients access trusted data, intelligence, and AI-powered workflows. “AI is not a feature we are adding to NIQ; it is core to our product strategy,” said Jim Peck, Chief Executive Officer of NIQ. “I
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom